| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 858.2MM | +7% |
| Gross Profit | 159.9MM | - |
| Cost Of Revenue | 698.3MM | +1% |
| Operating Income | -217.8MM | -53% |
| Operating Expenses | 377.7MM | - |
| Net Income | -254.5MM | -44% |
| G&A | 47.3MM | +5% |
| Amortization | 5.6MM | -20% |
| Interest Expense | 33.5MM | +4% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
PLYMOUTH MEETING, Pa., April 18, 2024--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2024 financial results before the opening of the financial markets on Tuesday, May 7, 2024. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
PLYMOUTH MEETING, Pa., April 17, 2024--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Suzanne Foster as its Chief Executive Officer. Ms. Foster will assume leadership of the Company from interim CEO and Chairman of the Board, Richard Barasch, on May 20, 2024.
AHCO vs. BSX: Which Stock Is the Better Value Option?
Here is how AdaptHealth Corp. (AHCO) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
AHCO vs. BSX: Which Stock Is the Better Value Option?
AHCO vs. HLN: Which Stock Is the Better Value Option?
Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.
PLYMOUTH MEETING, Pa., March 04, 2024--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, and Jason Clemens, CFO, will participate in the Barclays 26th Annual Global Healthcare Conference, being held in Miami, on Tuesday, March 12, 2024, including a fireside chat at 4
PLYMOUTH MEETING, Pa., March 01, 2024--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Richard Barasch, Chairman and interim CEO, and Jason Clemens, CFO, will participate in the 3rd Annual Jefferies Value Based Care Summit, being held in Miami, on Monday, March 11, 2024, including a fireside chat at 4:15pm